Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2010 - 2026)

Updated

Eli Lilly's Return on Invested Capital [ROIC] came in at 37.16% for Q2 2026, up 5.21 percentage points from 31.95% a year earlier but down 0.66 percentage points from the prior quarter.

Analysis

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2010 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Return on Invested Capital [ROIC] was 40.07%, up 7.90 percentage points from FY2024.

  • Return on Invested Capital [ROIC] carries a five-year change of +11.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Invested Capital [ROIC] was 32.17% in FY2024 (+6.18 pp), 25.99% in FY2023 (-1.80 pp), 27.79% in FY2022 (+0.37 pp) and 27.42% in FY2021 (-1.51 pp).
  • The five-year range for quarterly Return on Invested Capital [ROIC] is 22.36% (Q1 2023) to 37.83% (Q1 2026).
  • Year-over-year, Return on Invested Capital [ROIC] has increased for ten consecutive quarters, with an average year-over-year change of +5.52 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q1 2026 (a gain of 7.76 percentage points), and the weakest in Q2 2023 (a drop of 8.00 percentage points).
  • Business Quant data shows LLY's Return on Invested Capital [ROIC] at 37.83% (Q1 2026), 34.61% (Q4 2025) and 33.68% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.16%
Mar 31, 2026 37.83%
Dec 31, 2025 34.61%
Sep 30, 2025 33.68%
Jun 30, 2025 31.95%
Mar 31, 2025 30.06%
Dec 31, 2024 28.95%
Sep 30, 2024 25.97%
Jun 30, 2024 25.86%
Mar 31, 2024 24.35%
Dec 31, 2023 24.27%
Sep 30, 2023 24.65%
Jun 30, 2023 22.66%
Mar 31, 2023 22.36%
Dec 31, 2022 27.79%
Sep 30, 2022 29.73%
Jun 30, 2022 30.67%
Mar 31, 2022 29.51%
Dec 31, 2021 26.02%
Sep 30, 2021 27.17%
API Access

Eli Lilly Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY